Perihilar cholangiocarcinoma masquerading as intrahepatic cholestasis of pregnancy: a case report and review of the literature

Chao Xiao, Chengjian Cao, Xue Xiao, Qijun ChengFrontiers in Medicine 2024 · DOI

TL;DR

This paper details a rare and deceptive case of perihilar cholangiocarcinoma (pCCA)—a highly aggressive bile duct cancer—perfectly mimicking a common pregnancy-related liver condition. By reviewing the sparse existing literature, the authors highlight critical diagnostic red flags to help clinicians distinguish between routine gestational cholestasis and life-threatening malignancy.

What Problem Does This Paper Address?

Cholangiocarcinoma (CCA) is an aggressive cancer of the bile duct epithelium, typically seen in patients over 40. Because it is so rare in younger populations, its appearance during pregnancy often leads to a "diagnostic masquerade."

The primary challenge is that pCCA symptoms—specifically intense itching (pruritus), jaundice, and elevated bile acids—are nearly identical to Intrahepatic Cholestasis of Pregnancy (ICP), a much more common and less fatal condition. This overlap frequently leads to misdiagnosis or delayed diagnosis, which is catastrophic given that CCA has a 95% five-year mortality rate. The authors aim to provide a clinical roadmap for identifying these "hidden" tumors when standard pregnancy treatments fail.

Methods

The paper is structured in two parts:

  1. Case Report: A detailed clinical history of a 33-year-old pregnant woman, including her laboratory progression (liver enzymes, bile acids), imaging results (Color Doppler ultrasound and MRI), surgical intervention, and 26-month follow-up.
  2. Literature Review: A systematic search of the PubMed, Wanfang, and Embase databases for cases of CCA during pregnancy reported between 1975 and 2021. The authors synthesized data from 16 identified cases to find commonalities in symptoms, diagnostic timelines, and fetal outcomes.

Datasets

As a clinical case study and review, the "dataset" consists of:

  • The primary patient’s longitudinal lab data (Table 1 in the paper).
  • A cohort of 16 cases identified through the literature review, spanning 46 years of medical records.

Key Insights and Ideas

  • The Failure of First-Line Therapy as a Diagnostic Tool: In this case, the patient was treated with Ursodeoxycholic acid (UDCA), the standard treatment for ICP. When her bile acid levels continued to rise and her itching worsened despite medication, it served as a critical "red flag" that the diagnosis was not simple ICP.
  • The "Spider Sign": The authors highlight a specific ultrasound finding—dilated intrahepatic bile ducts appearing like a "spider" or "evil spirit" in the hepatic hilum—which can indicate pCCA even when a distinct tumor mass is not yet visible on a standard scan.
  • Diagnostic Mimicry: The review found that CCA doesn't just mimic ICP; it can also present similarly to HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) and Acute Fatty Liver of Pregnancy (AFLP), further complicating the obstetrician's job.
  • Imaging Constraints: While MRI is a powerful diagnostic tool, the authors emphasize that contrast agents (Gadolinium) must be avoided in pregnant patients due to risks of fetal stillbirth and neonatal death, making non-contrast imaging and ultrasound expertise vital.

Key Results

  • Clinical Outcome: The patient was diagnosed with pCCA (Bismuth stage IV, Stage IIIB). Despite an "inadequate" (palliative) surgical resection and the termination of her pregnancy, she survived for 26 months—significantly longer than the typical 3–6 month median survival for advanced CCA.
  • Literature Synthesis:
    • The 16 reviewed cases showed a wide onset range (16 weeks gestation to 2 weeks postpartum).
  • Fetal outcomes were poor: only two cases reached full-term delivery, with the rest resulting in abortions or premature births.
  • Prognosis remains dismal: 50% of the women in the literature review died shortly after diagnosis.

Limitations and Future Work

The primary limitation is the inherent rarity of the condition; with only 16 cases documented in nearly 50 years, it is difficult to establish a standardized "gold standard" for treatment. Furthermore, the paper notes that many common tumor markers (like CA15-3) are naturally elevated during ICP or normal pregnancy, rendering them unreliable for cancer screening in this specific population.

Future work is needed to identify pregnancy-specific biomarkers that can differentiate between benign gestational liver issues and biliary malignancies. The authors also call for increased awareness among obstetricians to consider malignancy when "typical" pregnancy symptoms follow an atypical clinical course.

Summary updated

Abstract

Cholangiocarcinoma (CCA) is a tumor that arises from the epithelium of the intrahepatic bile ducts. It is rarely diagnosed in individuals under 40 years of age and has a very aggressive nature: 95% of patients die within 5 years. We present the first detailed report of a case of perihilar CCA (pCCA) presenting during pregnancy masquerading as intrahepatic cholestasis of pregnancy (ICP). First, the patient exhibited typical pruritus, particularly in her limbs; second, a raised biomarker of total bile acid (TBA) was noted; third, the onset occurred in the second trimester, aligning with the epidemiological profile; and finally, importantly, there was no mass detected in her liver. First-line drugs were given to treat ICP, but they failed, and ultimately, the condition was identified as pCCA. Following an inadequate excision, traditional Chinese medicine was administered. After 26 months, she succumbed to cachexia. As gestational symptoms are sometimes associated with pregnancy-related disorders, pCCA in pregnant women is frequently misdiagnosed. Symptoms such as jaundice, pruritus, and dilated bile ducts in pregnant women may indicate pCCA. In addition, the appropriate treatment for pCCA in pregnant women may be surgery or chemotherapy; if surgery is not an option, chemotherapy may also help extend the gestational week. Our work is important and can educate on the diagnosis and treatment of pregnancy-related diseases, such as ICP and pCCA.
BibTeX
@inproceedings{xiao2024perihilar,
  author = {Chao Xiao and Chengjian Cao and Xue Xiao and Qijun Cheng},
  title = {{Perihilar cholangiocarcinoma masquerading as intrahepatic cholestasis of pregnancy: a case report and review of the literature}},
  booktitle = {Frontiers in Medicine},
  year = {2024},
  doi = {10.3389/fmed.2024.1449865},
}
Figure